The Quiet Campaign for Genetically Engineered Humans
By Richard Hayes,
Earth Island Journal, Spring 2001
| 11. 30. 2000
We are fast approaching the most consequential technological threshold in all of human history: the ability to directly manipulate the genes we pass on to our children.
Development and use of these technologies would irrevocably change the nature of human life and human society. It would destabilize human biological identity and function. It would put into play a wholly unprecedented set of social, psychological and political forces that would feed back upon themselves with impacts quite beyond our ability to imagine, much less control.
These technologies are being developed and promoted by an influential network of scientists who see themselves ushering in a new epoch for human life on Earth. They look forward to the day when parents can quite literally assemble their children from genes listed in a catalog. They celebrate a future in which our common humanity is lost as a genetically enhanced elite increasingly acquires the attributes of a separate species.
There is little public awareness of the full implications of the new human genetic engineering (HGE) technologies or of the campaign to promote them. There are...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...